6 July 2006
Panel Discussion: Nanotechnology Safety and Environmental Issues Deborah Willcocks, International Conference on Nanotechnology and Nanoscience, Brisbane QLD
17 & 18 July 2006
Nanomaterials: Technical Issues and Role of OECD Deborah Willcocks, Nanotechnology International Workshop on Regulatory Challenges, Melbourne VIC
7 October 2006
The Make-Up of Cosmetic Regulations: The Role of the Pharmacist Roshini Jayewardene, 12 th Pharmacy Australia Congress, Cairns QLD
24 October 2006
Triclosan : the potential for bioaccumulation, to cause harm to breast-fed babies and methodology for risk characterization Sneha Satya; Beryllium and beryllium compounds Helen Ritchie, Advisory Group on Chemical Safety, Canberra ACT
31 October 1 November 2006
NICNAS and the Laboratory Bob Graf, Laboratory Managers Conference 2006, Science Industry Australia, Melbourne VIC
10 November 2006
Overview of Nanomaterials: Regulatory Activities Deborah Willcocks, ACCORD industry meeting, Sydney NSW
11 December 2006
NICNAS Overview of Nanomaterials, International Activities on Nanomaterials Deborah Willcocks, National Health and Medical Research Council Nanotechnology Roundtable, Canberra ACT
6 February 2007
Outcomes of the International Workshop on Skin Sensitisation in Chemical Risk Assessment Paul Harvey; PentaBDE Hazard Classification and LOAEL Identification Kerry Nugent, Advisory Group on Chemical Safety, Canberra ACT
27 February 2007Current NICNAS Reform Activities Bob Graf, PACIA NSW Regulatory Affairs seminar, Sydney NSW
2 March 2007
Lead Compounds in Industrial Surface Coatings and Inks International Stephen Zaluzny, International Paint and Inks Conference, Sydney NSW
10 May 2007NICNAS Review of Existing Chemicals Program Bob Graf, with Liz Hanna, CEF, HAZMAT 2007, Sydney NSW
23 May 2007
Cosmetic Regulation in Australia Hana Hamdan, Australian Society of Cosmetic Chemists Meeting, Sydney NSW
24 May 2007
NICNAS: New directions and perspectives Marian Healy, ACCORD Briefing and AGM, Melbourne VIC
5 June 2007
Decabromodiphenyl ether ( decaBDE): Hazard assessment Carcinogenicity study interpretation Kerry Nugent, Advisory Group on Chemical Safety, Canberra ACT